ArticlePrzeglad menopauzalny = Menopause review2026
Prevalence, diagnosis, and management of dysmenorrhea among Polish women: a cross-sectional study.
Article in Przeglad menopauzalny = Menopause review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Dysmenorrhea is a common condition that significantly impacts women's quality of life, yet it remains underdiagnosed and inadequately treated. This study aimed to assess its prevalence, clinical characteristics, diagnostic pathways, and treatment strategies among Polish women. Material and methods: A cross-sectional survey was conducted among 1,172 women aged 17-66 years (mean 29.4 ±8.7) using a structured questionnaire covering demographics, comorbidities, symptom profile, diagnostic processes, and treatment approaches. Results: Dysmenorrhea was reported by 95.8% of participants, with 69.7% experiencing symptoms regularly. Pain intensity was high (mean visual analogue scale [VAS] 7.77 ±1.65), and most women reported impairment in daily activities (78.4%) and work performance (87%). The average number of sick leave days was 8.92 per year. Symptoms typically lasted 1-3 days and were frequently accompanied by systemic manifestations such as weakness, diarrhoea, back pain, and fatigue. Only 43% of respondents sought medical evaluation, with a mean diagnostic delay of 4.2 years. Among diagnosed cases (29.1%), endometriosis, polycystic ovary syndrome, and uterine fibroids were most common. Hormonal therapy was the most frequently used treatment (42.8%), followed by analgesics and surgical interventions. While 58.7% of participants reported improvement, 25% experienced no benefit. Treatment-related adverse effects were common (74.3%). Pain intensity decreased significantly after treatment (mean VAS 4.24 ±2.6; Conclusions: Dysmenorrhea is highly prevalent and substantially affects daily functioning among Polish women. Delayed diagnosis and limited treatment effectiveness highlight the need for improved management strategies and greater clinical awareness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.